BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7684186)

  • 1. Expression of the proliferating cell nuclear antigen in the different types of Hodgkin's disease.
    Hell K; Lorenzen J; Hansmann ML; Fellbaum C; Busch R; Fischer R
    Am J Clin Pathol; 1993 May; 99(5):598-603. PubMed ID: 7684186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Which are the proliferating cells in Hodgkin's disease?].
    Hell K; Lorenzen J; Hansmann ML; Fellbaum C; Busch R; Fischer R
    Verh Dtsch Ges Pathol; 1992; 76():155-8. PubMed ID: 1283249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease.
    Schmid C; Sweeney E; Isaacson PG
    J Pathol; 1992 Sep; 168(1):1-6. PubMed ID: 1360494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype of Hodgkin and Sternberg-Reed cells and expression of CD57 (LEU7) antigen.
    Papadimitriou CS; Bai MK; Kotsianti AJ; Costopoulos JS; Hytiroglou P
    Leuk Lymphoma; 1995 Dec; 20(1-2):125-30. PubMed ID: 8750633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percentage of proliferating cell nuclear antigen (PCNA)-positive Reed-Sternberg cells in nodular sclerosis Hodgkin's disease.
    Kordek R; Biernat W; Niewiadomska H; Kupnicka D; Woźniak L; Domagała W; Osborn M
    Patol Pol; 1993; 44(3):129-31. PubMed ID: 7902558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferating cells in Hodgkin's disease].
    Schmid C; Isaacson PG
    Verh Dtsch Ges Pathol; 1992; 76():151-4. PubMed ID: 1283248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.
    Schmid C; Pan L; Diss T; Isaacson PG
    Am J Pathol; 1991 Oct; 139(4):701-7. PubMed ID: 1656757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varied B-cell immunophenotypes of Hodgkin/Reed-Sternberg cells in classic Hodgkin's disease.
    Watanabe K; Yamashita Y; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Histopathology; 2000 Apr; 36(4):353-61. PubMed ID: 10759950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
    Ohsawa M; Aozasa K; Ikeda H
    Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease.
    Carbone A; Gloghini A; Aldinucci D; Gattei V; Dalla-Favera R; Gaidano G
    Br J Haematol; 2002 May; 117(2):366-72. PubMed ID: 11972519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.
    Freeman J; Kellock DB; Yu CC; Crocker J; Levison DA; Hall PA
    J Clin Pathol; 1993 May; 46(5):446-9. PubMed ID: 8100573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-predominance Hodgkin's disease.
    Poppema S
    Int Rev Exp Pathol; 1992; 33():53-79. PubMed ID: 1733872
    [No Abstract]   [Full Text] [Related]  

  • 14. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
    Siebert JD; McClure SP; Banks PM; Gulley ML
    Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of proliferating cell nuclear antigen (PCNA/Cyclin) in workshop cases of Hodgkin's disease and non-Hodgkin's lymphoma.
    Kamel OW; Warnke RA; Banks PM
    Semin Diagn Pathol; 1992 Nov; 9(4):311-4. PubMed ID: 1362284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues.
    Della Croce DR; Imam A; Brynes RK; Nathwani BN; Taylor CR
    Hematol Oncol; 1991; 9(2):103-14. PubMed ID: 1869241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
    Kraus MD; Haley J
    Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.